Abstract:Objective: Buddleja officinalis is used as a natural Chinese medicine and contains flavonoids that may be beneficial to the treatment of dry eye. Methods: Sixty postmenopausal females diagnosed with dry eye were assigned to treatment with Buddleja officinalis eye drops and artificial tears (n=30) or a control treatment with artificial tears only (n=30). The analysis of subjective symptoms of the ocular surface, the Ocular Surface Disease Index (OSDI), tear film function, tear protein levels and confocal scanning microscopy results were analyzed at pre-therapy and following 1, 2, 4, and 8 weeks of therapy. Results: Following 8 weeks of therapy, all the indices of the patients treated with Buddleja officinalis eye drops were improved compared with those pre-therapy (P < 0.05), but those in the control group were not. All indices at 8 weeks presented statistically significant differences between the two groups (all P < 0.05). In addition, the mean density of inflammatory cells and corneal epithelium basal cells of the patients treated with Buddleja officinalis eye drops was reduced compared with the men density of the control (P < 0.05). Conclusion: These results show that Buddleja officinalis eye drops provided a clinical benefit in relieving the symptoms of moderate to severe dry eye in postmenopausal females.

Buddleja Officinalis Eye Drops Alleviate The Symptoms Of Moderate To Severe Dry Eye